WebMay 27, 2024 · Five Prime Therapeutics Stock Price (Quote) $38.00 ( 0% ) Friday, 27th May 2024 Historical Five Prime Therapeutics prices « 1 2 3 4 5 6 7 8 9 10 ... 32 33 » … WebMar 15, 2024 · A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FPRX shares currently have a short interest ratio of 1.0. Learn More on Five Prime Therapeutics's short interest ratio.
FIVE PRIME THERAPEUTICS, INC. 2013 OMNIBUS INCENTIVE PLAN TABLE FIVE ...
WebFIVE PRIME THERAPEUTICS, INC. 2010 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:OCTOBER 28, 2010 APPROVED BY THESTOCKHOLDERS: DECEMBER 9, 2010 TERMINATION DATE:OCTOBER 27, 2024 from FIVE PRIME THERAPEUTICS INC filed with the Securities and Exchange Commission. ... The … WebApr 9, 2024 · Five Prime Therapeutics (NASDAQ:FPRX) has a recorded net income of -$137.20 million. FPRX has generated -$3.92 earnings per share over the last four quarters. What is Five Prime Therapeutics's EPS forecast for next year? Five Prime Therapeutics's earnings are expected to grow from ($2.29) per share to ($2.13) per share in the next year. photoful
Five Prime Therapeutics - FPRX Stock Forecast, Price
WebFive Prime Therapeutics (FPRX) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. WebFIVE PRIME THERAPEUTICS, INC. STOCK OPTION GRANT NOTICE (2002 EQUITY INCENTIVE PLAN) from FIVE PRIME THERAPEUTICS INC filed with the Securities and Exchange Commission. ... Exercise Price (Per Share): $0.37. Total Exercise Price: $55,500.00. Expiration Date: October 20, 2024 . Type of Grant: WebNov 13, 2024 · Five Prime estimates that the net proceeds from the sale of the shares will be approximately $141.9 million, after deducting underwriting discounts and … how does the silk road impact us today